W Adams - National HealthCare Director
| NHC Stock | USD 105.96 0.21 0.20% |
Insider
W Adams is Director of National HealthCare since 2009.
| Age | 73 |
| Tenure | 15 years |
| Address | 100 East Vine Street, Murfreesboro, TN, United States, 37130 |
| Phone | 615 890 2020 |
| Web | https://www.nhccare.com |
W Adams Latest Insider Activity
Tracking and analyzing the buying and selling activities of W Adams against National HealthCare stock is an integral part of due diligence when investing in National HealthCare. W Adams insider activity provides valuable insight into whether National HealthCare is net buyers or sellers over its current business cycle. Note, National HealthCare insiders must abide by specific rules, including filing SEC forms every time they buy or sell National HealthCare'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
W Adams over three weeks ago Disposition of 7500 shares by W Adams of National HealthCare at 77.92 subject to Rule 16b-3 | ||
W Adams over two months ago Disposition of tradable shares by W Adams of National Health subject to Rule 16b-3 |
National HealthCare Management Efficiency
The company has Return on Asset of 0.0275 % which means that on every $100 spent on assets, it made $0.0275 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0889 %, implying that it generated $0.0889 on every 100 dollars invested. National HealthCare's management efficiency ratios could be used to measure how well National HealthCare manages its routine affairs as well as how well it operates its assets and liabilities. At present, National HealthCare's Return On Assets are projected to slightly decrease based on the last few years of reporting. At present, National HealthCare's Return On Tangible Assets are projected to slightly decrease based on the last few years of reporting. The current year's Intangibles To Total Assets is expected to grow to 0.14, whereas Total Assets are forecasted to decline to about 772 M.Similar Executives
| Showing other executives | INSIDER Age | ||
| Barbara CPA | InnovAge Holding Corp | 61 | |
| Kevin Connor | Encompass Health Corp | 53 | |
| Maria Lozzano | InnovAge Holding Corp | 44 | |
| Anthony Hernandez | Encompass Health Corp | 58 | |
| Terrance Williams | Encompass Health Corp | 52 | |
| Patrick Esq | Healthcare Services Group | 49 | |
| CPA CPA | Healthcare Services Group | 50 | |
| Joel Veit | Select Medical Holdings | N/A | |
| JD Kennedy | InnovAge Holding Corp | 63 | |
| Brent Guerisoli | Pennant Group | 43 | |
| Andrew Brophy | Healthcare Services Group | 34 | |
| RN MHA | InnovAge Holding Corp | 62 | |
| John Gochnour | Pennant Group | 41 | |
| Gregory Carmichael | Encompass Health Corp | 59 | |
| Derek Bunker | Pennant Group | 36 | |
| Ryan Kubota | InnovAge Holding Corp | N/A | |
| Matthew MBA | Healthcare Services Group | N/A | |
| Patricia Maryland | Encompass Health Corp | 67 | |
| Rob Borella | InnovAge Holding Corp | N/A | |
| L Shaw | Encompass Health Corp | 75 | |
| Olivia Patton | InnovAge Holding Corp | N/A | |
Management Performance
| Return On Equity | 0.0889 | ||||
| Return On Asset | 0.0275 |
National HealthCare Leadership Team
Elected by the shareholders, the National HealthCare's board of directors comprises two types of representatives: National HealthCare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of National. The board's role is to monitor National HealthCare's management team and ensure that shareholders' interests are well served. National HealthCare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, National HealthCare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert Adams, Non-Executive Chairman of the Board | ||
| Brian Kidd, Senior Vice President Principal Accounting Officer, Controller | ||
| Leroy McIntosh, Senior Vice President- Ancillary Services And Service Line Strategy. | ||
| W Adams, Director | ||
| Ernest Burgess, Independent Director | ||
| Stephen Flatt, Chief Executive Officer, Director | ||
| Richard LaRoche, Independent Director | ||
| Michael Ussery, President, Chief Operating Officer | ||
| Emil Hassan, Independent Director | ||
| Jeffrey Smith, Senior Vice President Treasurer | ||
| Anderson Sr, Senior Officer | ||
| Carl Adams, Founder | ||
| J Abernathy, Independent Director | ||
| Vicki Dodson, Senior Vice President - Patient Services | ||
| Josh McCreary, Senior Vice President General Counsel, Secretary | ||
| R Ussery, President, Chief Operating Officer | ||
| B Flatt, Senior Vice President, Chief Information Officer |
National Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is National HealthCare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0889 | ||||
| Return On Asset | 0.0275 | ||||
| Profit Margin | 0.07 % | ||||
| Operating Margin | 0.05 % | ||||
| Current Valuation | 1.5 B | ||||
| Shares Outstanding | 15.4 M | ||||
| Shares Owned By Insiders | 19.72 % | ||||
| Shares Owned By Institutions | 55.53 % | ||||
| Number Of Shares Shorted | 509.79 K | ||||
| Price To Earning | 22.85 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| MSFT | Microsoft | |
| CRM | Salesforce | |
| GOOG | Alphabet Inc Class C |
Additional Information and Resources on Investing in National Stock
When determining whether National HealthCare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National HealthCare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Healthcare Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National HealthCare. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. For information on how to trade National Stock refer to our How to Trade National Stock guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National HealthCare. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National HealthCare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.224 | Dividend Share 2.36 | Earnings Share 5.27 | Revenue Per Share 75.942 | Quarterly Revenue Growth 0.102 |
The market value of National HealthCare is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National HealthCare's value that differs from its market value or its book value, called intrinsic value, which is National HealthCare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National HealthCare's market value can be influenced by many factors that don't directly affect National HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National HealthCare's value and its price as these two are different measures arrived at by different means. Investors typically determine if National HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National HealthCare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.